Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis

NCT05957107 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection

Sponsor

Beijing VDJBio Co., LTD.